Comparison of Her2/Neu Oncoprotein in Serum and Tissue Samples in Women with Breast Cancer

BACKGROUND AND OBJECTIVES: Human Epidermal Growth Factor Receptor 2 (HER2/neu) is one of the most extensively studied proto-oncogens in breast cancer patients. Accurate and timely assessment of the HER2/neu over expression is pivotal for the identification of breast cancer patients that could benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokhrel, Rakesh, Yadav, Binod Kumar, Sharma, Nisha, Sharma, Vijay Kumar, Tuladhar, Eans Tara, Raut, Mithileshwor, Bhattarai, Aseem, Dubey, Raju Kumar, Niraula, Apeksha, Mishra, Akash, Budhathoki, Uttam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272608/
https://www.ncbi.nlm.nih.gov/pubmed/35225453
http://dx.doi.org/10.31557/APJCP.2022.23.2.429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272608/
https://www.ncbi.nlm.nih.gov/pubmed/35225453
http://dx.doi.org/10.31557/APJCP.2022.23.2.429

Ejemplares similares